Abstract: This invention relates to novel uses of recombinant clostridial neurotoxins exhibiting decreased duration of effect, in particular uses for the treatment of patients having experienced muscle-related disorders and/or injuries.

Abstract: This invention relates to novel uses of recombinant clostridial neurotoxins exhibiting decreased duration of effect, in particular uses for the treatment of patients suffering from a limited range of muscle extension, in particular from flexion contracture, in particular flexion contracture of the knee, and more particularly uses for the treatment of such patients having experienced a total knee arthroplasty.

Abstract: This invention relates to novel uses of recombinant clostridial neurotoxins exhibiting decreased duration of effect, in particular uses for the treatment of patients having experienced tendon-related disorders and/or injuries.

Abstract: This invention relates to novel uses of recombinant clostridial neurotoxins exhibiting decreased duration of effect, in particular uses for the treatment of different forms of back pain, in particular recurrent low back pain.

Abstract: The present invention relates to a patch comprising a layer composition, wherein the layer composition comprises at least a backing liner, a matrix layer comprising an onion extract (A), an acrylate based polymer (B) or a thermoplastic hot melt adhesive (B*), and a release liner, wherein the matrix layer is disposed between the backing liner and the release liner such that the matrix layer is contacted by the backing liner and the release liner on opposite sides thereof, wherein the release liner is releasable from the matrix layer. Further the present invention relates to such a patch for use in treating and/or preventing scars.